Cefuroxime (cefuroxime): Reviews and patient testimonials

Cefuroxime 1.5g powder for solution for injection or infusion

Cefuroxime is indicated for the treatment of infections listed below in adults and children, including neonates (from birth) (see sections 4.4 and 5.1).

• Community acquired pneumonia

• Acute exacerbations of chronic bronchitis

• Complicated urinary tract infections, including pyelonephritis

• Soft-tissue infections: cellulitis, erysipelas and wound infections

• Intra-abdominal infections

• Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular and gynaecological surgery (including caesarean section)

In treatment and prevention of infections in which it is very likely that anaerobic organisms will be encountered, cefuroxime should be administered with additional appropriate antibacterial agents.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Cefuroxime 250mg powder for injection vials

Cefuroxime 250mg Powder for Injection is indicated for the treatment of infections caused by susceptible strains of the designated micro-organisms, or before the infecting organism has been identified, in the diseases listed below:

Respiratory tract infections for example, acute and chronic bronchitis, infected bronchiectasis. bacterial pneumonia, lung abscess and post operative chest infections.

Ear, nose and throat infections for example, sinusitis, tonsillitis and pharyngitis.

Urinary tract infections for example acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria.

Soft-tissue infections such as cellulitis, erysipelas, peritonitis and wound infections

Bone and joint infections for example, osteomyelitis and septic arthritis

Obstetric and gynaecological infections pelvic inflammatory disease

Gonorrhoea particularly where penicillin is not suitable

Other infections including septicaemia and meningitis

Prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, oesophageal and vascular surgery where there is increased risk from infection.

Consideration should be given to official local guidance (e.g. national recommendations) on the appropriate use of antibacterial agents.

Susceptibility of the causative organism to the treatment should be tested (if possible), although therapy may be initiated before the results are available.

Cefuroxime 250mg powder for solution for injection

Cefuroxime is indicated for the treatment of infections listed below in adults and children, including neonates (from birth) (see sections 4.4 and 5.1).

• Community acquired pneumonia

• Acute exacerbations of chronic bronchitis

• Complicated urinary tract infections, including pyelonephritis

• Soft-tissue infections: cellulitis, erysipelas and wound infections

• Intra-abdominal infections

• Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular and gynaecological surgery (including caesarean section)

In treatment and prevention of infections in which it is very likely that anaerobic organisms will be encountered, cefuroxime should be administered with additional appropriate antibacterial agents.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Cefuroxime 250mg tablets

Cefuroxime axetil is indicated for the treatment of the infections listed below in adults and children from the age of 3 months (see sections 4.4 and 5.1).

- Acute streptococcal tonsillitis and pharyngitis.

- Acute bacterial sinusitis.

- Acute otitis media.

- Acute exacerbations of chronic bronchitis.

- Cystitis

- Pyelonephritis.

- Uncomplicated skin and soft tissue infections.

- Treatment of early Lyme disease.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Cefuroxime 750mg powder for solution for injection

Cefuroxime is indicated for the treatment of infections listed below in adults and children, including neonates (from birth) (see sections 4.4 and 5.1).

• Community acquired pneumonia

• Acute exacerbations of chronic bronchitis

• Complicated urinary tract infections, including pyelonephritis

• Soft-tissue infections: cellulitis, erysipelas and wound infections

• Intra-abdominal infections

• Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular and gynaecological surgery (including caesarean section)

In treatment and prevention of infections in which it is very likely that anaerobic organisms will be encountered, cefuroxime should be administered with additional appropriate antibacterial agents.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Cefuroxime Sodium Injection

Cefuroxime sodium for injection is indicated for the treatment of infections listed below in adults and children, including neonates (from birth) (see sections 4.4 and 5.1).

• Community acquired pneumonia

• Acute exacerbations of chronic bronchitis

• Complicated urinary tract infections, including pyelonephritis

• Soft-tissue infections: cellulitis, erysipelas and wound infections

• Intra-abdominal infections

• Prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section)

In the treatment and prevention of infections in which it is very likely that anaerobic organisms will be encountered, cefuroxime should be administered with additional appropriate antibacterial agents.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Route of administration: Injectable, Oral
Molecule: cefuroxime